x

MIRA PHARMACEUTICALS, INC. (Nasdaq:MIRA)

Health Care/Life Sciences • Pharmaceuticals
CIK 1904286
Company

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company engages in developing its product candidate, MIRA1a, as a synthetic cannabinoid analog for treating anxiety & chronic pain by targeting the cannabinoid type 1 and type 2 (CB1 and CB2) receptors. MIRA Pharmaceuticals was founded by Adam Kaplin on September 3, 2020 and is headquartered in Miami, FL.

Address
1200 Brickell Avenue
Suite 1950 1183
Miami, Florida 33131
Employees
3
Stock Info
Close
$1.0100
Day Range
0.8859 - 1.0300
52 Week Range
0.5100 - 5.0100
Average volume
360.48K
Short Interest
701.87K (02/14/25)
% of Float Shorted
5.81%
Market Cap
$16.73M
Revenue
N/A
Net Income
-$11.98M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$0.7287
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chairman & Chief Executive Officer
Erez Aminov
Independent Director
Matthew P. Del Giudice
Independent Director
Denil Nanji Shekhat
Independent Director
Edward MacPherson
SEC filings
DateFormEvent
20 Dec, 2024 8-K
19 Dec, 2024 8-K
10 Dec, 2024 4
10 Dec, 2024 4
10 Dec, 2024 4
10 Dec, 2024 4
10 Dec, 2024 8-K
10 Dec, 2024 4
10 Dec, 2024 4
27 Nov, 2024 4
26 Nov, 2024 3
21 Nov, 2024 8-K
19 Nov, 2024 144
19 Nov, 2024 8-K
12 Nov, 2024 10-Q
25 Oct, 2024 8-K
21 Oct, 2024 8-K
27 Sep, 2024 424B5
27 Sep, 2024 S-8
12 Sep, 2024 8-K
10 Sep, 2024 8-K
6 Sep, 2024 144/A
4 Sep, 2024 144
30 Aug, 2024 4
23 Aug, 2024 8-K
16 Aug, 2024 10-Q/A
16 Aug, 2024 EFFECT
15 Aug, 2024 CORRESP
15 Aug, 2024 UPLOAD
13 Aug, 2024 10-Q
12 Aug, 2024 S-3
9 Aug, 2024 8-K
8 Aug, 2024 8-K
26 Jul, 2024 DEF 14A
26 Jul, 2024 DEFA14A
24 Jul, 2024 8-K
19 Jul, 2024 8-K
12 Jul, 2024 8-K
28 Jun, 2024 8-K
21 Jun, 2024 4
30 May, 2024 4
29 May, 2024 8-K
22 May, 2024 4
13 May, 2024 10-Q
1 Apr, 2024 10-K
27 Mar, 2024 4
27 Mar, 2024 4
27 Mar, 2024 4
27 Mar, 2024 4
27 Mar, 2024 4
27 Mar, 2024 4
22 Mar, 2024 3
22 Mar, 2024 3
22 Mar, 2024 3
13 Mar, 2024 8-K
7 Mar, 2024 8-K
17 Jan, 2024 8-K
27 Dec, 2023 SC 13D/A
27 Dec, 2023 4
27 Dec, 2023 EFFECT
22 Dec, 2023 CORRESP
22 Dec, 2023 UPLOAD
18 Dec, 2023 S-1
1 Dec, 2023 8-K
20 Nov, 2023 8-K
20 Nov, 2023 3
20 Nov, 2023 SC 13D/A
17 Nov, 2023 4
14 Nov, 2023 424B3
13 Nov, 2023 10-Q
3 Nov, 2023 3
25 Oct, 2023 8-K
12 Oct, 2023 3
12 Oct, 2023 SC 13D/A
18 Sep, 2023 424B3
15 Sep, 2023 10-Q
31 Aug, 2023 8-K
24 Aug, 2023 4
21 Aug, 2023 4
21 Aug, 2023 4
21 Aug, 2023 4
21 Aug, 2023 4
14 Aug, 2023 SC 13D
7 Aug, 2023 8-K
4 Aug, 2023 4
4 Aug, 2023 424B4
4 Aug, 2023 424B1 IPO completed
2 Aug, 2023 3
2 Aug, 2023 3
2 Aug, 2023 3
2 Aug, 2023 3
2 Aug, 2023 3
2 Aug, 2023 3
2 Aug, 2023 3
2 Aug, 2023 3
2 Aug, 2023 3
2 Aug, 2023 EFFECT
2 Aug, 2023 3
31 Jul, 2023 CORRESP
31 Jul, 2023 CORRESP
31 Jul, 2023 CERT
31 Jul, 2023 8-A12B
28 Jul, 2023 S-1/A
25 Jul, 2023 S-1/A
21 Jul, 2023 S-1/A
18 Jul, 2023 S-1/A
14 Jul, 2023 CORRESP
13 Jul, 2023 CORRESP
10 Jul, 2023 UPLOAD
29 Jun, 2023 S-1
29 Jun, 2023 CORRESP
15 Jun, 2023 UPLOAD
8 Jun, 2023 DRSLTR
8 Jun, 2023 DRS/A
30 May, 2023 UPLOAD
2 May, 2023 DRS/A
1 Aug, 2022 D
1 Aug, 2022 D
29 Jun, 2022 DRS
Last update:2025-03-06 12:23:02.526966
MIRA PHARMACEUTICALS, INC. by TradingView

Sign Up to Subscribe